PREFRIN A LIQ .12 %
PHENYLEPHRINE HYDROCHLORIDE : .12 % PYRILAMINE MALEATE : .1 % · DIN 00400408 · ALLERGAN INC
Health Canada status: CANCELLED POST MARKET
What is PREFRIN A LIQ?
PREFRIN A LIQ .12 % contains PHENYLEPHRINE HYDROCHLORIDE : .12 % PYRILAMINE MALEATE : .1 %. It is listed in the Health Canada Drug Product Database under DIN 00400408, held by ALLERGAN INC, supplied as LIQUID for OPHTHALMIC administration. Health Canada currently lists it as cancelled post market, status dated 16-Jul-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00400408 |
|---|---|
| Brand name | PREFRIN A LIQ |
| Generic / active ingredient | PHENYLEPHRINE HYDROCHLORIDE : .12 % PYRILAMINE MALEATE : .1 % |
| Manufacturer | ALLERGAN INC |
| Strength | .12 % |
| Dosage form | LIQUID |
| Route of administration | OPHTHALMIC |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | S01GA55 PHENYLEPHRINE, COMBINATIONS |
| AHFS class | 52:32.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 16-Jul-2012 |
| Original market date | 1978-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code S01GA55 PHENYLEPHRINE, COMBINATIONS. 0 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DIOROUGE LIQ | 0.125 % | SOLUTION | PHARMA STULLN INC. | DORMANT | DIN 02026511 |
| OCCU-CAL DROPS | 1.9 MG | DROPS | PRODUITS FRANCAIS LABS INC. | CANCELLED POST MARKET | DIN 00540935 |
| OCCU-CAL LOTION | 11.1 MG | LOTION | PRODUITS FRANCAIS LABS INC. | CANCELLED POST MARKET | DIN 00540927 |
| ODAN-VERNACON | 0.5 % | SOLUTION | ODAN LABORATORIES LTD | DORMANT | DIN 00626643 |
| PHENYLEPHRINE/HYDROXYETHYLCELLULOSE | 0.5 % | SOLUTION | PHARMA STULLN INC. | DORMANT | DIN 02026473 |
| ZINCFRIN | .25 % | LIQUID | ALCON CANADA INC | CANCELLED POST MARKET | DIN 00042595 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.